Brochure More information from

(1)

Brochure

More information from http://www.researchandmarkets.com/reports/1801564/

Drug Delivery Devices Market Outlook in India to 2017 - Metered Dose

Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free

Injections

Description: Drug Delivery Devices Market Outlook in India to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Summary

GlobalData’s new report, “Drug Delivery Devices Market Outlook in India to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections” provides key market data on the India Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the four market categories.

- Global corporate-level profiles of key companies operating within the India Drug Delivery Devicesmarket. - Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Fresenius Kabi AG, Baxter International Inc., Cipla Ltd. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the India Drug Delivery Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Contents: 1

1

1.1 List of Tables 1.2 List of Figures 2 Introduction

2.1 What is This Report About? 3 Drug Delivery Devices In India

3.1 Drug Delivery Devices, Market Segmentation

(2)

3.4 Drug Delivery Devices Market, India, Category Contribution (%), 2010 3.5 Drug Delivery Devices, India, Category Volume (Units), 2003-2017 3.6 Drug Delivery Devices, India, Company Share (2009-2010) 4 Central Venous Catheters In India

4.1 Central Venous Catheters, Market Segmentation

4.2 Central Venous Catheters Market, India, Revenue Mix ($m), 2010 4.3 Central Venous Catheters Market, India, Segment Contribution (%), 2010 4.4 Central Venous Catheters Overall Revenue (2003-2017)

4.5 Central Venous Catheters Overall Volume (2003-2017) 4.6 Central Venous Catheters Average Price (2003-2017) 4.7 Central Venous Catheters Distribution Share (2009-2010) 4.8 Central Venous Catheters, India, Company Share (2009-2010) 5 Infusion Systems In India

5.1 Infusion Systems, Market Segmentation

5.2 Infusion Systems Market, India, Revenue Mix ($m), 2010 5.3 Infusion Systems Market, India, Segment Contribution (%), 2010 5.4 Infusion Systems Overall Revenue (2003-2017)

5.4.1 Syringe Pumps Revenue (2003-2017)

5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017) 5.5 Infusion Systems Overall Volume (2003-2017) 5.5.1 Syringe Pumps Volume (2003-2017)

5.5.2 Ambulatory Infusion Pumps Volume (2003-2017) 5.6 Infusion Systems Average Price (2003-2017) 5.7 Infusion Systems Distribution Share (2009-2010) 5.8 Infusion Systems, India, Company Share (2009-2010) 6 Metered Dose Inhaler Devices In India

6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 6.5 Metered Dose Inhaler Devices, India, Company Share (2009-2010) 7 Needle Free Injections In India

7.1 Needle Free Injections Overall Revenue (2003-2017) 7.2 Needle Free Injections Overall Volume (2003-2017) 7.3 Needle Free Injections Average Price (2003-2017) 7.4 Needle Free Injections Distribution Share (2009-2010)

8 Overview of Key Companies in India Drug Delivery Devices Market 8.1 GlaxoSmithKline plc

8.1.1 Company Overview

8.1.2 Share in the India Drug Delivery Devices Market 8.2 AstraZeneca PLC

8.2.2 Share in the India Drug Delivery Devices Market 8.3 Boehringer Ingelheim GmbH

8.3.2 Share in the India Drug Delivery Devices Market 8.4 Fresenius Kabi AG

8.4.2 Share in the India Drug Delivery Devices Market 8.5 Baxter International Inc.

8.5.2 Share in the India Drug Delivery Devices Market 8.6 Cipla Ltd.

(3)

8.11 Smiths Medical 8.11.1 Company Overview 8.12 JMS CO., LTD. 8.12.1 Company Overview 8.13 NIPRO CORPORATION 8.13.1 Company Overview 8.14 Medtronic, Inc. 8.14.1 Company Overview

8.15 Edwards Lifesciences Corporation 8.15.1 Company Overview

8.16 B. Braun Melsungen AG 8.16.1 Company Overview

8.17 Becton, Dickinson and Company 8.17.1 Company Overview

8.18 Consort Medical plc 8.18.1 Company Overview 8.19 3M Health Care 8.19.1 Company Overview

9 Drug Delivery Devices Market Pipeline Products 10 Recent Developments

10.1 Strategy and Business Planning

10.1.1 Jan 17, 2011: Smiths Medical To Set Up Subsidiary In India 10.2 Government and Public Interest

10.2.1 Sep 08, 2010: Wipro GE Healthcare Healthcare Wins FICCI Healthcare Excellence Award 11 Appendix

11.1 Definitions of Markets Covered in the Report 11.1.1 Drug Delivery Devices

11.2 Research Methodology 11.3 Secondary Research 11.4 Primary Research 11.5 Models 11.6 Forecasts 11.7 Expert Panels 11.8 Consulting 11.9 Currency Conversion 11.10 Contact Us 11.11 Disclaimer 1.1 List of Tables

Table 1: Drug Delivery Devices, India, Overall Revenue ($m), 2003-2017 Table 2: Drug Delivery Devices Market, India, Category Contribution (%), 2010 Table 3: Drug Delivery Devices, India Cross-Category Analysis, 2003-2017 Table 4: Drug Delivery Devices, India, Overall Revenue ($m), Historic, 2003-2010 Table 5: Drug Delivery Devices, India, Overall Revenue ($m), Forecast, 2010-2017 Table 6: Drug Delivery Devices, India, Category Volume (Units), 2003-2017

Table 7: Drug Delivery Devices, India, Category Volume (Units), Historic, 2003-2010 Table 8: Drug Delivery Devices, India, Category Volume (Units), Forecast, 2010-2017 Table 9: Drug Delivery Devices, India, Company Share by Revenue ($m), 2009-2010 Table 10: Central Venous Catheters Market, India, Segment Contribution (%), 2010 Table 11: Central Venous Catheters, India, Revenue ($m) by Segment, Historic, 2003-2010 Table 12: Central Venous Catheters, India, Revenue ($m) by Segment, Forecast, 2010-2017 Table 13: Central Venous Catheters, India, Volume (Units) by Segment, Historic, 2003-2010 Table 14: Central Venous Catheters, India, Volume (Units) by Segment, Forecast, 2010-2017 Table 15: Central Venous Catheters, India, Average Price ($), Historic, 2003-2010

Table 16: Central Venous Catheters, India, Average Price ($), Forecast, 2010-2017

Table 17: Central Venous Catheters, India, Distribution Share by Revenue ($m), 2009-2010 Table 18: Central Venous Catheters, India, Company Share by Revenue ($m), 2009-2010 Table 19: Infusion Systems Market, India, Segment Contribution (%), 2010

Table 20: Infusion Systems, India, Revenue ($m) by Segment, Historic, 2003-2010 Table 21: Infusion Systems, India, Revenue ($m) by Segment, Forecast, 2010-2017 Table 22: Syringe Pumps, India, Revenue ($m) by Sub-Segment, Historic, 2003-2010 Table 23: Syringe Pumps, India, Revenue ($m) by Sub-Segment, Forecast, 2010-2017

(4)

Table 25: Ambulatory Infusion Pumps, India, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 Table 26: Infusion Systems, India, Volume (Units) by Segment, Historic, 2003-2010

Table 27: Infusion Systems, India, Volume (Units) by Segment, Forecast, 2010-2017 Table 28: Syringe Pumps, India, Volume (Units) by Sub-Segment, Historic, 2003-2010 Table 29: Syringe Pumps, India, Volume (Units) by Sub-Segment, Forecast, 2010-2017

Table 30: Ambulatory Infusion Pumps, India, Volume (Units) by Sub-Segment, Historic, 2003-2010 Table 31: Ambulatory Infusion Pumps, India, Volume (Units) by Sub-Segment, Forecast, 2010-2017 Table 32: Infusion Systems, India, Average Price ($), Historic, 2003-2010

Table 33: Infusion Systems, India, Average Price ($), Forecast, 2010-2017

Table 34: Infusion Systems, India, Distribution Share by Revenue ($m), 2009-2010 Table 35: Infusion Systems, India, Company Share by Revenue ($m), 2009-2010 Table 36: Metered Dose Inhaler Devices, India, Revenue ($m), Historic, 2003-2010 Table 37: Metered Dose Inhaler Devices, India, Revenue ($m), Forecast, 2010-2017 Table 38: Metered Dose Inhaler Devices, India, Volume (Units), Historic, 2003-2010 Table 39: Metered Dose Inhaler Devices, India, Volume (Units), Forecast, 2010-2017 Table 40: Metered Dose Inhaler Devices, India, Average Price ($), Historic, 2003-2010 Table 41: Metered Dose Inhaler Devices, India, Average Price ($), Forecast, 2010-2017

Table 42: Metered Dose Inhaler Devices, India, Distribution Share by Revenue ($m), 2009-2010 Table 43: Metered Dose Inhaler Devices, India, Company Share by Revenue ($m), 2009-2010 Table 44: Needle Free Injections, India, Revenue ($m), Historic, 2003-2010

Table 45: Needle Free Injections, India, Revenue ($m), Forecast, 2010-2017 Table 46: Needle Free Injections, India, Volume (Units), Historic, 2003-2010 Table 47: Needle Free Injections, India, Volume (Units), Forecast, 2010-2017 Table 48: Needle Free Injections, India, Average Price ($), Historic, 2003-2010 Table 49: Needle Free Injections, India, Average Price ($), Forecast, 2010-2017

Table 50: Needle Free Injections, India, Distribution Share by Revenue ($m), 2009-2010 Table 51: Drug Delivery Devices Market Pipeline Products

Table 52: USD to Local Currency, India, Average Actual Rate 2003-2010 1.2 List of Figures

Figure 1: Drug Delivery Devices, Market Segmentation

Figure 2: Drug Delivery Devices, India, Overall Revenue ($m), 2003-2017 Figure 3: Drug Delivery Devices Market, India, Revenue Mix ($m), 2010 Figure 4: Drug Delivery Devices Market, India, Category Contribution (%), 2010 Figure 5: Drug Delivery Devices Market, India, Cross-Category Analysis, 2003-2017 Figure 6: Drug Delivery Devices, India, Overall Revenue ($m), Historic, 2003-2010 Figure 7: Drug Delivery Devices, India, Overall Revenue ($m), Forecast, 2010-2017 Figure 8: Drug Delivery Devices, India, Category Volume (Units), 2003-2017

Figure 9: Drug Delivery Devices, India, Category Volume (Units), Historic, 2003-2010 Figure 10: Drug Delivery Devices, India, Category Volume (Units), Forecast, 2010-2017 Figure 11: Drug Delivery Devices, India, Company Share (%), 2010

Figure 12: Central Venous Catheters, Market Segmentation

Figure 13: Central Venous Catheters Market, India, Revenue Mix ($m), 2010 Figure 14: Central Venous Catheters Market, India, Segment Contribution (%), 2010 Figure 15: Central Venous Catheters, India, Revenue ($m) by Segment, Historic, 2003-2010 Figure 16: Central Venous Catheters, India, Revenue ($m) by Segment, Forecast, 2010-2017 Figure 17: Central Venous Catheters, India, Volume (Units) by Segment, Historic, 2003-2010 Figure 18: Central Venous Catheters, India, Volume (Units) by Segment, Forecast, 2010-2017 Figure 19: Central Venous Catheters, India, Company Share (%), 2010

Figure 20: Infusion Systems, Market Segmentation

Figure 21: Infusion Systems Market, India, Revenue Mix ($m), 2010 Figure 22: Infusion Systems Market, India, Segment Contribution (%), 2010 Figure 23: Infusion Systems, India, Revenue ($m) by Segment, Historic, 2003-2010 Figure 24: Infusion Systems, India, Revenue ($m) by Segment, Forecast, 2010-2017 Figure 25: Syringe Pumps, India, Revenue ($m) by Sub-Segment, Historic, 2003-2010 Figure 26: Syringe Pumps, India, Revenue ($m) by Sub-Segment, Forecast, 2010-2017

Figure 27: Ambulatory Infusion Pumps, India, Revenue ($m) by Sub-Segment, Historic, 2003-2010 Figure 28: Ambulatory Infusion Pumps, India, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 Figure 29: Infusion Systems, India, Volume (Units) by Segment, Historic, 2003-2010

Figure 30: Infusion Systems, India, Volume (Units) by Segment, Forecast, 2010-2017 Figure 31: Syringe Pumps, India, Volume (Units) by Sub-Segment, Historic, 2003-2010 Figure 32: Syringe Pumps, India, Volume (Units) by Sub-Segment, Forecast, 2010-2017

(5)

Figure 34: Ambulatory Infusion Pumps, India, Volume (Units) by Sub-Segment, Forecast, 2010-2017 Figure 35: Infusion Systems, India, Company Share (%), 2010

Figure 36: Metered Dose Inhaler Devices, India, Revenue ($m), Historic, 2003-2010 Figure 37: Metered Dose Inhaler Devices, India, Revenue ($m), Forecast, 2010-2017 Figure 38: Metered Dose Inhaler Devices, India, Volume (Units), Historic, 2003-2010 Figure 39: Metered Dose Inhaler Devices, India, Volume (Units), Forecast, 2010-2017 Figure 40: Metered Dose Inhaler Devices, India, Company Share (%), 2010

Figure 41: Needle Free Injections, India, Revenue ($m), Historic, 2003-2010 Figure 42: Needle Free Injections, India, Revenue ($m), Forecast, 2010-2017 Figure 43: Needle Free Injections, India, Volume (Units), Historic, 2003-2010 Figure 44: Needle Free Injections, India, Volume (Units), Forecast, 2010-2017

Figure 45: GlaxoSmithKline plc, Company Share (%),India Drug Delivery Devices Market, 2010 Figure 46: AstraZeneca PLC, Company Share (%),India Drug Delivery Devices Market, 2010

Figure 47: Boehringer Ingelheim GmbH, Company Share (%),India Drug Delivery Devices Market, 2010 Figure 48: Fresenius Kabi AG, Company Share (%),India Drug Delivery Devices Market, 2010

Figure 49: Baxter International Inc., Company Share (%),India Drug Delivery Devices Market, 2010 Figure 50: Cipla Ltd., Company Share (%),India Drug Delivery Devices Market, 2010

Ordering: Order Online - http://www.researchandmarkets.com/reports/1801564/

Order by Fax - using the form below

Order by Post - print the order form below and send to Research and Markets,

(6)

Page 1 of 2

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit

http://www.researchandmarkets.com/contact/

Order Information

Please verify that the product information is correct and select the format(s) you require.

Product Formats

Please select the product formats and quantity you require:

Contact Information

Please enter all the information below in BLOCK CAPITALS

Product Name: Drug Delivery Devices Market Outlook in India to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections Web Address: http://www.researchandmarkets.com/reports/1801564/

Office Code: SC

Quantity

Electronic (PDF)

-Site License: USD 5000 Electronic (PDF)

-Enterprisewide: USD 7500 Electronic (PDF)

-Single User: USD 2500

Title: Mr Mrs Dr Miss Ms Prof

First Name: Last Name:

Email Address: * Job Title: Organisation: Address: City:

Postal / Zip Code: Country:

Phone Number: Fax Number:

(7)

Page 2 of 2

Payment Information

Please indicate the payment method you would like to use by selecting the appropriate box.

Please fax this form to:

(646) 607-1907 or (646) 964-6609 - From USA

+353-1-481-1716 or +353-1-653-1571 - From Rest of World

Pay by credit card: You will receive an email with a link to a secure webpage to enter your_{credit card details.}

Pay by check: Please post the check, accompanied by this form, to: Research and Markets,

Guinness Center, Taylors Lane, Dublin 8, Ireland.

Pay by wire transfer: Please transfer funds to:

Account number 833 130 83

Sort code 98-53-30

Swift code ULSBIE2D

IBAN number IE78ULSB98533083313083 Bank Address _{Ulster Bank,}

27-35 Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below:

Marketing Code: